U.S. federal trademark · Serial No. 75489412 · Reg. No. 2151851
Pharmaceuticals for the treatment of inflammatory diseases including arthritis, psoriasis and vasculitis, cardiovascular diseases including myocardial infarction, congestive heart failure, atherosclerosis and stroke, metabolic diseases such as diabetes, cancer, neurodegenerative diseases such as multiple sclerosis, infectious diseases including bacterial, viral and parasitic diseases, and for use in organ transplantation; pharmaceuticals, namely protein therapeutic agents for the treatment of the aforesaid diseases, and for use in organ transplantation; pharmaceuticals, namely, prodrugs for the treatment of the aforesaid diseases and for use in organ transplantation; pharmaceuticals, namely polypeptides for the treatment of the aforesaid diseases and for use in organ transplantation; veterinary preparations for the treatment of inflammation, cancer and infectious diseases in pets and in livestock
Medical and scientific research services relating to discovery, development or improvement of chemical, medical and veterinary preparations; medical and scientific research services relating to modification of pharmaceutically useful molecules, protein therapeutic agents and polypeptides, immunonotherapeutic agents, molecular adjuvants and vaccines
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.